PhRMA的动态

A.forall's 'No More Shortages' services assist hospitals in finding needed medications ???????? ?? We're providing access to medicines that are not yet licensed in certain regions, but which are still necessary for patient care. ?? Diverse teams from different countries are working tirelessly to share expertise and break down barriers in sourcing medicines. ?? All in all, since 2022, A.forall's businesses have fulfilled over 1.3 million equivalent months of missing patient treatments. Healthcare partners - learn more on nomoreshortages.com #OneMission #MakingAffordableMedicinesAvailableToAll

Consumer interest in GLP-1 medications is increasing, with many viewing them as a promising solution for weight loss. How can healthcare teams better support patients in this journey? Take a look at some key insights from patients and physicians: https://bit.ly/3Tzi4T4 #GLP1 #HealthSystems #Ozempic

Discussing drug affordability can be controversial or even politicized, but in my opinion, the need for affordable access to medical care and treatments should not be a political issue.? ? In my practice, I see people struggling every day with impossible decisions—choosing to reduce medication efficacy due to affordability challenges or being unable to afford life-saving drugs altogether. These patients face life-or-death choices, not because a treatment or cure doesn't exist, but because they can't afford the medication.? ? As a physician, my hands are tied, and it's heartbreaking to watch patients suffer when the necessary care is available but out of reach due to cost. ? ? I believe it's imperative that the healthcare system evolves to ensure that accessing the medications prescribed by physicians is straightforward and affordable. Patients should not have to face barriers when it comes to obtaining the treatments they need for a healthy life. Addressing these challenges is crucial for improving patient outcomes and ensuring everyone receives the care they need. ? ? #medications #healthcare #medicine #patienthealth

Each day, #biosimilars provide essential care for millions of people around the globe. Whether you’re a patient, healthcare provider, regulator, or an industry professional, join us in supporting #GlobalBiosimilars Week and learning these life-changing medicines. https://lnkd.in/d_cpUnQ

Very interesting read describing an approach which can dramatically reduce drug spend with the flip of a switch at the point of ePrescribing.

?? Tackling Drug Diversion: The Key to a Safer Healthcare Environment ?? In the ever-evolving sector of healthcare, the issue of drug diversion stands as a pivotal concern that requires our immediate attention. It poses serious risks, not only to patient safety, but also to the integrity of our medical institutions. Shedding light on drug diversion is our goal at Protenus. Join our comprehensive webinar to learn how to effectively monitor and manage this critical issue. Industry experts will share insights on building a robust drug diversion program with practical advice and leading strategies. ?? Watch the Measuring the Success of Your Drug Diversion Program on-demand webinar now: https://bit.ly/4bzkCbn #Protenus #PatientPrivacy #DrugDiversionPrevention #Healthcaretech

#ClinicalTrials make tomorrow’s medicines and treatment options possible, but they can only happen with your help. Visit https://ow.ly/gui750Rjupc today, then share it with others in your life. https://ow.ly/CwuR50Rjupg

Earlier this month, Sarah Butler, chief commercial officer at ADVI Health, spoke with Pharmacy Times to discuss the potential impact of the #InflationReductionAct on drug prices and #patientaccess. Additionally, Sarah elaborated on some of the bigger challenges for patients such as managing the cost of medication, the upcoming election, and how pharmacists and other #healthcare providers can collaborate with payers to help ensure access and affordability. Read more on Sarah's insights: https://lnkd.in/etjHe-BQ

When countries use tendering processes to select which medicines to make affordable for patients, it limits choice and makes it less likely patients will be able to?access new treatment options. Tendering processes delay access to breakthrough therapies and prevent doctors from being able to prescribe the most suitable medicine for a patient’s individual needs or circumstances. A Stronger PBS will make more medicines available at subsidised rates and give clinicians and patients greater choice for better health outcomes. Learn more >>?https://lnkd.in/gJUGZW-p